SCHEMBL7158886

SCHEMBL7158886

C=C[C@@]1(OC(=O)c2ccccc2)[C@@H](COC(=O)c2ccccc2)O[C@@H](n2ccc(N)nc2=O)[C@@H]1OC(=O)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ST6GAL1 P15907 4/20 0.40
▸ LMNA P02545 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ MTOR P42345 1/20 0.38
▸ MDM2 Q00987 1/20 0.38
▸ NCOA1 Q15788 1/20 0.38
▸ NCOA3 Q9Y6Q9 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ NT5E P21589 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ PDE3A Q14432 1/20 0.36
▸ SLC29A1 Q99808 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ POLA1 P09884 2/20 0.35
▸ HTT P42858 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7163188 0.83 POLB (0.43) NT5ESLC29A1MEN1USP2POLB
SCHEMBL7157425 0.83 NT5E (0.40) ST6GAL1LMNATHRBMTORMDM2
SCHEMBL16131588 0.81 ST6GAL1 (0.40) ST6GAL1LMNATHRBMTORMDM2
SCHEMBL7166943 0.81 NT5E (0.38) ST6GAL1LMNATHRBMTORMDM2
SCHEMBL7165495 0.80 ST6GAL1 (0.37) ST6GAL1LMNATHRBMTORMDM2
SCHEMBL1425303 0.77 ST6GAL1 (0.46) ST6GAL1LMNATHRBMTORMDM2
SCHEMBL7162756 0.76 ALDH1A1 (0.40) LMNAALDH1A1MEN1USP2POLB
SCHEMBL12702718 0.76 LMNA (0.41) ST6GAL1LMNATHRBMTORMDM2
SCHEMBL7162658 0.75 ALDH1A1 (0.39) ALDH1A1
SCHEMBL19594217 0.74 PDE4D (0.44) ST6GAL1LMNATHRBMTORMDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0747389-B1 3'-SUBSTITUTED NUCLEOSIDE DERIVATIVES TAIHO PHARMACEUTICAL CO LTD (JP) 2003-09-10 — — EP disclosed
US-RE38090-E1 Antitumor activity; useful for treatment and prevention of cancers Matsuda, Akira (JP) 2003-04-22 — — US disclosed
US-5763418-A NUCLEOTIDE ANTITUMOR AGENTS Matsuda, Akira (JP) 1998-06-09 — — US disclosed
EP-0747389-A1 3'-SUBSTITUTED NUCLEOSIDE DERIVATIVES TAIHO PHARMACEUTICAL CO., LTD. (JP) 1996-12-11 — — EP disclosed
Send feedback